PATINA Trial - Dr. Olivier Told You So!!!
Feb: Timothée Olivier, MD, flagged PATINA's open-label, investigator-assessed PFS. Jun: FDA approval. Oct: EMA says benefits “had not been demonstrated.”
DESTINY-Breast09 is Trending, What About PATINA?
Breast Cancer experts from the global KOL community have been buzzing about DESTINY-Breast09 and PATINA clinical trials. Track their social media insights.